Cellworks | Best-in-Class PTRS & Personalized Therapy Decision Support

Precision Biosimulation

Improve drug development and patient outcomes

WATCH VIDEO

Clinical Lung Cancer
Cellworks Study Uses Integrative Genomics
to Predict Benefit of Adding Chemotherapy to
Immunotherapy in Metastatic NSCLC
READ PUBLICATION

Precise

PHARMA

Improve therapy success through precision drug development

Read More

Personalized treatments for your patients

PHYSICIAN

Extend lives with cancer treatment predictors

Read More

PATIENT

Personalized treatment today for a better tomorrow

Read More

Insured support for cancer treatment

PAYER

Effective intervention for better patient outcomes prolongs lives and saves costs

Read More

Drug development through software cell modeling

Precision by Biosimulation

BIOSIMULATION
PLATFORM

PRECISION MEDICINE PRODUCTS

FEATURED CONTENT

FEATURED ARTICLE

Cellworks Study Supports Liquid Biopsy for Predicting Chemo-Immunotherapy Benefit in Advanced NSCLC

FEATURED PUBLICATION

Use of an Integrative Genomics Approach to Identify Metastatic NSCLC Patients Benefiting From the Addition of Chemotherapy to Immune Checkpoint Inhibitors

FEATURED VIDEO

View how personalized therapy biosimulation works

FEATURED BLOG

Beyond AI: The Critical Role of Biology in Personalized Cancer Therapy

NEWS

Cellworks Study Supports Liquid Biopsy for Predicting Chemo-Immunotherapy…

New findings show potential for liquid biopsy to expand access to personalized tr…

Cellworks Presents Novel Mechanistic Approach to Predicting Drug–Drug…

Study suggests biologically grounded predictions could reduce safety-related failures in comb…

COLLABORATORS

OUR PARTNERS IN REVOLUTIONIZING CANCER TREATMENT.

Top